MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    From Subclinical Symptoms to Post-Surgical Challenges: A Pediatric Case of Craniopharyngioma

    M. Gomez Rodriguez, H. Torocsik (Pembroke Pines, USA)

    Objective: To provide a case of subclinical symptoms including motor tics in a child found to have a large craniopharyngioma with post surgical parkinsonism. Background:…
  • 2025 International Congress

    Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations

    H. Mayo, A. Negida, M. Ahsan, S. Lageman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: The objective of the study was to identify EEG features associated with cognitive fluctuations in patients with Lewy body dementia (LBD). Background: Cognitive fluctuations…
  • 2025 International Congress

    Longitudinal FDG-PET Study of Metabolic Trajectories and Connectivity Alterations in Multiple System Atrophy

    Y. Zhao, H. Lin, X. Li, F. Liu, J. Wang (Shanghai, China)

    Objective: 本研究使用 FDG-PET 探索 MSA 中葡萄糖代谢和网络连接的纵向变化,以辅助早期诊断和监测疾病进展。 Background: Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease with distinct metabolic patterns in its parkinsonian (MSA-P)…
  • 2025 International Congress

    Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine

    N. Guragain, R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)

    Objective: To understand the pattern of movement disorders caused by migraine prophylactic medicine such as flunarizine. Background: Migraine prophylactic treatments are usually taken for short…
  • 2025 International Congress

    Outcomes of Algorithm Guided DBS Programming: A case series

    M. Ferris, J. Kim, B. Reid, V. Buch (Palo Alto, USA)

    Objective: With the growing availability of technology-guided deep brain stimulation (DBS) programming, it is increasingly challenging to determine when and how to use these technologies…
  • 2025 International Congress

    Altered Tryptophan Metabolism and the Role of the Kynurenine Pathway in Multiple System Atrophy

    R. Nagao, K. Kawabata, Y. Mizutani, H. Watanabe (Toyoake, Japan)

    Objective: To elucidate cerebrospinal fluid (CSF) tryptophan metabolism in multiple system atrophy (MSA), focusing on alterations in the kynurenine pathway and its pathological implications. Background:…
  • 2025 International Congress

    White Matter Abnormalities in Progressive Supranuclear Palsy (PSP) vs. Parkinson’s Disease (PD): Evaluation with a Convolutional Neural Network (CNN)-Based Tool

    S. Zaheer, Y. Patel, M. Abarghouei Emamikhah, N. Bendahan, R. Zou, M. Malik, N. Owsicki, N. Paul, Q. Nguyen Victor, A. Boutet, A. Lang (Toronto, Canada)

    Objective: This study aimed to compare white matter hyperintensity (WMH) burden between PSP and PD using a novel AI-based tool for more accurate WMH volume…
  • 2025 International Congress

    Quantitative Gait Evaluation in Multiple System Atrophy: Supervised versus Unsupervised Analysis

    F. Marchand, J. Labreuche, T. Ollivier, D. Guehl, A. Delval, L. Defebvre, AK. Berger, J. Wiedemann, L. Kjaersgaard, T. Warlop, A. Fasano, BR. Bloem, D. Devos, C. Moreau (Lille, France)

    Objective: This study aims to compare gait parameters in real-world (RW) home settings with supervised clinical assessments on 6-minutes walking test (6MWT) in MSA patients…
  • 2025 International Congress

    Carbidopa/levodopa related hypotension in patients with alpha-synucleinopathies

    D. Rebolledo, JA. Romero-Mera, JC. Lopez-Hernandez, M. Groccopatel-Marra, A. Gonzalez-Duarte, P. Millar Vernetti, H. Kaufmann (New York, USA)

    Objective: Evaluate blood pressure response to levodopa/carbidopa in patients with synucleinopathies undergone to autonomic testing. Background: Carbidopa/levodopa is the mainstay treatment of patients with synucleinopathies,…
  • 2025 International Congress

    The importance of vascular anomalies and endothelin-1 factor in the development of vascular parkinsonism

    R. Juraev, R. Matmurodov, S. Jumanazarova (Tashkent, Uzbekistan)

    Objective: To study the relationship between vascular endothelium and vascular anomalies in the development of vascular parkinsonism. Background: Although vascular parkinsonism (VP) is relatively rare,…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley